Finance

Lists
IMNM:NASDAQ
Immunome Inc
$27.13
+3.35%
(+0.88) 1D
Aug 12, 11:57:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMNM...
Open
$25.23
High
$27.75
Low
$25.23
Mkt. cap
3.07B
Avg. vol.
1.21M
Volume
524.74K
52-wk high
$27.75
52-wk low
$8.66
EPS
-$2.36
Beta
2.08
Shares outstanding
113.25M
No. of employees
206
Open
$25.23
High
$27.75
Low
$25.23
Mkt. cap
3.07B
Avg. vol.
1.21M
Volume
524.74K
52-wk high
$27.75
52-wk low
$8.66
EPS
-$2.36
Beta
2.08
Shares outstanding
113.25M
No. of employees
206
News stories
From web sources and news partners
About Immunome Inc
CEO-
Employees206
Founded2006
HeadquartersBothell, Washington, United States
SectorBiotechnology
Websiteimmunome.com
Analyst ratings
Based on 13 analysts giving stock ratings to IMNM in the past 3 months
Strong buy
Buy
13
Hold
0
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for IMNM in the last 3 months.
Highest
Current $27.13
$40.00 (+47.44%)
Average
$36.00 (+32.69%)
Lowest
$30.00 (+10.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Cory Kasimov
Evercore ISI
Buy
Maintained
$40.00
+47.4%
08/12/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
$36.00
+32.7%
08/12/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
$38.00
+40.1%
08/12/2026
Biren Amin
Piper Sandler
Buy
Maintained
$33.00
+21.6%
08/12/2026
Charles Zhu
LifeSci Capital
Buy
Reiterated
$40.00
+47.4%
08/12/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$40.00
+47.4%
08/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/11/2026
Unknown Analyst
Wedbush
Buy
Maintained
$35.00
+29%
08/12/2026
Lukas Shumway
Barclays
Buy
Maintained
$36.00
+32.7%
07/09/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
06/29/2026
Chad Messer
Lake Street
Buy
Maintained
$30.00
+10.6%
06/01/2026
Unknown Analyst
Barclays
Buy
Initiated
$36.00
+32.7%
05/28/2026
Andrew Berens
Leerink Partners
Buy
Maintained
$33.00
+21.6%
05/15/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$35.00
+29%
05/13/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$35.00
+29%
05/12/2026
Karina Rabayeva
Truist Financial
Buy
Maintained
-
-
03/05/2026
Sudan Loganathan
Stephens
Buy
Reiterated
$30.00
+10.6%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.02M
-
-
-
Cost of goods sold
40.45M
49.19M
50.77M
46.38M
Cost of revenue
40.45M
49.19M
50.77M
46.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.04M
10.94M
12.09M
12.95M
Operating expense
10.04M
10.94M
12.09M
12.95M
Total operating expenses
50.49M
60.14M
62.86M
59.33M
Operating income
-46.48M
-60.14M
-62.86M
-59.33M
Other non operating income
-
-
-
-
EBT including unusual items
-43.40M
-57.46M
-69.90M
-53.84M
EBT excluding unusual items
-43.40M
-57.46M
-59.90M
-53.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.40M
-57.46M
-69.90M
-53.84M
Net profit margin
-1,080.87%
-
-
-
Earnings per share
-0.50
-0.65
-0.76
-0.48
Interest and investment income
3.08M
2.68M
2.96M
5.49M
Interest expense
-
-
-
-
Net interest expenses
3.08M
2.68M
2.96M
5.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.84M
-59.55M
-62.23M
-58.73M
Gain or loss from assets sale
891.00K
-50.00K
55.00K
79.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps